RenalytixAI To Announce Financial Results for Full Year Ended June 30, 2020 and Provide Corporate Update
NEW YORK, Oct. 16, 2020 /PRNewswire/ -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announces that it will report its audited financial results for the full year ended June 30, 2020 on Tuesday, October 27 2020.
Analyst conference call
Conference Call Details
Conference ID: 7673467
Webcast Registration link:
UK Retail Investor presentation
The presentation will be hosted through the digital platform Investor Meet Company. Investors can sign up to Investor Meet Company for free and add to meet RenalytixAI plc via the following link:
For those investors who have already registered and added to meet the Company, they will automatically be invited.
About Kidney Disease
View original content to download multimedia:http://www.prnewswire.com/news-releases/renalytixai-to-announce-financial-results-for-full-year-ended-june-30-2020-and-provide-corporate-update-301153816.html